Exceptional Responders With Solid Tumor Cancer to Chemotherapy

NCT02555735 · clinicaltrials.gov ↗

ENROLLING_BY_INVITATION

Status

250

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor Neoplasms

Interventions

DRUG: Standard of Care Chemotherapy

Sponsor

Adera Labs, LLC

Collaborators

[object Object]